DYN position history
The shares of Dyne Therapeutics (DYN) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q1: 333,391 shares, $3.5M, 0.66% of portfolio, New
- 2025 Q2: 264,976 shares, $2.5M, 0.54% of portfolio, Reduce −20.5%
- 2025 Q3: 1,262,674 shares, $16M, 3.0% of portfolio, Add +376.5%
- 2025 Q4: 1,472,197 shares, $29M, 4.0% of portfolio, Add +16.6%
- 2026 Q1: 1,652,972 shares, $30M, 4.6% of portfolio, Add +12.3%
- 2026 Q2: 1,647,521 shares, $37M, 5.1% of portfolio, Reduce −0.3%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|